Elagolix

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds
Xconomy
Sat, 05/30/20 - 08:00 pm
AbbVie
FDA
uterine fibroids
Elagolix
Oriahnn
Myovant's uterine fibroid drug looks competitive in PhIII — but can they vanquish mighty AbbVie?
Endpoints
Tue, 07/23/19 - 10:05 am
Myovant
uterine fibroids
Relugolix
AbbVie
Elagolix
Myovant hits goal in uterine fibroid phase 3, teeing up AbbVie showdown
Fierce Biotech
Tue, 05/14/19 - 09:26 am
Myovant Sciences
Relugolix
clinical trials
uterine fibroids
AbbVie
Elagolix
AbbVie extension study tees up elagolix for uterine fibroids
Biopharma Dive
Thu, 08/23/18 - 04:30 pm
AbbVie
uterine fibroids
Elagolix
clinical trials
3 Biotech Stocks With Major Potential Catalysts in July
Yahoo/Motley Fool
Wed, 06/27/18 - 09:45 am
Neurocrine Biosciences
AbbVie
Progenics
INSYS Therapeutics
Elagolix
endometriosis
Azedra
adrenal tumors
Syndros
AbbVie's elagolix could put pressure on budgets, ICER estimates
Biopharma Dive
Tue, 05/8/18 - 03:46 pm
AbbVie
endometriosis
ICER
Elagolix
Elagolix review extended
Tue, 04/10/18 - 04:36 pm
FDA Requires More Time to Review Abbvie and Neurocrine Endometriosis Drug Elagolix
CP Wire
Tue, 04/10/18 - 09:30 am
AbbVie
Neurocrine
FDA
Elagolix
endometriosis
3 Biotechs That Could Get Big Boosts in April
Motley Fool
Wed, 03/28/18 - 10:02 am
biotech
GW Pharma
Epidiolex
Incyte
olumiant
baricitinib
Neurocrine Biosciences
Elagolix
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
Thu, 03/22/18 - 09:21 am
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
Is This AbbVie's Next Blockbuster Drug?
Motley Fool
Tue, 03/13/18 - 09:34 pm
AbbVie
Elagolix
uterine fibroids
AbbVie rolls up another big win for elagolix as the prospective blockbuster sweeps endpoints in latest PhIII
Endpoints
Wed, 02/21/18 - 09:36 am
AbbVie
Elagolix
endometriosis
uterine fibroids
Watch These Biotechs and the FDA Calendar
TheStreet.com
Sun, 02/11/18 - 01:23 pm
FDA
biotech
Dynavax
HEPLISAV-B
Progenics
Azedra
Neurocrine
Elagolix
AbbVie
3 Big Biotech Stocks With Major Catalysts on the Way
Motley Fool
Tue, 01/30/18 - 09:50 am
biotech
AbbVie
Neurocrine Biosciences
Elagolix
Celgene
ozanimod
Gilead Sciences
bictegravir
The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate
Endpoints
Sun, 12/17/17 - 11:47 am
drug launches
Bictegravir/F/TAF
Gilead Sciences
semaglutide
Novo Nordisk
epacadostat
Incyte
Rova-T
AbbVie
ozanimod
Celgene
apalutamide
JNJ
Elagolix
AVXS-101
AveXis
lanadelumab
Shire
Epidiolex
GW Pharma
Neurocrine Poised To Corner Tardive Dyskinesia Market With Ingrezza
Seeking Alpha
Tue, 07/11/17 - 09:36 am
Neurocrine Biosciences
Ingrezza
tardive dyskinesia
Elagolix
uterine fibroids
AbbVie preps an FDA pitch of promising PhIII data for blockbuster hopeful elagolix
Endpoints
Sat, 05/20/17 - 01:13 pm
AbbVie
Elagolix
clinical trials
endometriosis
3 Biggest Risks for AbbVie in 2017
Motley Fool
Wed, 12/28/16 - 11:03 am
AbbVie
Humira
biosimilars
Imbruvica
Viekira Pak
Elagolix
risankizumab
Elagolix May Become a Leading Uterine Fibroids Drug
Market Realist
Tue, 11/29/16 - 05:35 pm
uterine fibroids
Elagolix
AbbVie
Neurocrine Biosciences
Neurocrine Biosciences Starts A Data-Rich Year On The Right Foot
Seeking Alpha
Fri, 01/9/15 - 07:02 pm
Neurocrine Biosciences
AbbVie
Elagolix

Pages